Cargando…
Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival
PURPOSE: 2019 Coronavirus disease (COVID-19) is endangering health of populations worldwide. Latest research has proved that Lianhua Qingwen granules (LHQW) can reduce tissue damage caused by inflammatory reactions and relieve patients’ clinical symptoms. However, the mechanism of LHQW treats COVID-...
Autores principales: | Cao, Jun-Feng, Gong, Yunli, Wu, Mei, Xiong, Li, Chen, Shengyan, Huang, Haonan, Zhou, Xinge, Peng, Ying-chun, Shen, Xue-fang, Qu, Jinyu, Wang, Yi-li, Zhang, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729774/ https://www.ncbi.nlm.nih.gov/pubmed/36506032 http://dx.doi.org/10.3389/fcimb.2022.1044770 |
Ejemplares similares
-
The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis
por: Zhang, Qiongshuai, et al.
Publicado: (2020) -
Exploring the mechanism of action of Xuanfei Baidu granule (XFBD) in the treatment of COVID-19 based on molecular docking and molecular dynamics
por: Xiong, Li, et al.
Publicado: (2022) -
The Adverse Reactions of Lianhua Qingwen Capsule/Granule Compared With Conventional Drug in Clinical Application: A Meta-Analysis
por: Hu, Caiyun, et al.
Publicado: (2022) -
Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects
por: Li, Liu-Cheng, et al.
Publicado: (2020) -
Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19
por: Xia, Qi‐Dong, et al.
Publicado: (2020)